Absence of major fibrotic adverse events in hyperprolactinemic patients treated with cabergoline

University Medical Utrecht, A M E Stades, G D Valk, M J Cramer, F Teding van Berkhout, P M J Zelissen

Research output: Contribution to journalArticleAcademicpeer-review

43 Citations (Scopus)
75 Downloads (Pure)

Fingerprint

Dive into the research topics of 'Absence of major fibrotic adverse events in hyperprolactinemic patients treated with cabergoline'. Together they form a unique fingerprint.

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science